[go: up one dir, main page]

WO2000000614A3 - NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI) - Google Patents

NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI) Download PDF

Info

Publication number
WO2000000614A3
WO2000000614A3 PCT/US1999/014375 US9914375W WO0000614A3 WO 2000000614 A3 WO2000000614 A3 WO 2000000614A3 US 9914375 W US9914375 W US 9914375W WO 0000614 A3 WO0000614 A3 WO 0000614A3
Authority
WO
WIPO (PCT)
Prior art keywords
helicobacter pylori
novel antigens
novel
polypeptides
pylori
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/014375
Other languages
French (fr)
Other versions
WO2000000614A2 (en
WO2000000614A9 (en
Inventor
James Peter Fulginiti
Michael James Fiske
Deborah Ann Dilts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Priority to AU47189/99A priority Critical patent/AU4718999A/en
Priority to CA002329264A priority patent/CA2329264A1/en
Publication of WO2000000614A2 publication Critical patent/WO2000000614A2/en
Publication of WO2000000614A9 publication Critical patent/WO2000000614A9/en
Publication of WO2000000614A3 publication Critical patent/WO2000000614A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to novel nucleic acids and polypeptides relating to Helicobacter pylori, in particular novel H. pylori bacterial surface proteins having molecular weights of approximately 75, 77, and 79 kilo daltons (kDa). The nucleic acid sequences and polypeptides are useful for diagnostic and therapeutic purposes.
PCT/US1999/014375 1998-06-26 1999-06-25 NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI) Ceased WO2000000614A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU47189/99A AU4718999A (en) 1998-06-26 1999-06-25 Novel antigens of (helicobacter pylori)
CA002329264A CA2329264A1 (en) 1998-06-26 1999-06-25 Novel antigens of helicobacter pylori

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9085198P 1998-06-26 1998-06-26
US60/090,851 1998-06-26

Publications (3)

Publication Number Publication Date
WO2000000614A2 WO2000000614A2 (en) 2000-01-06
WO2000000614A9 WO2000000614A9 (en) 2000-03-30
WO2000000614A3 true WO2000000614A3 (en) 2000-05-04

Family

ID=22224631

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/014375 Ceased WO2000000614A2 (en) 1998-06-26 1999-06-25 NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI)

Country Status (3)

Country Link
AU (1) AU4718999A (en)
CA (1) CA2329264A1 (en)
WO (1) WO2000000614A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012908A1 (en) * 1995-10-04 1997-04-10 Pasteur Merieux Serums & Vaccins NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI
WO1997037044A1 (en) * 1996-03-29 1997-10-09 Astra Aktiebolag Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
WO1997047646A1 (en) * 1996-06-10 1997-12-18 Boren Thomas Helicobacter pylori adhesin binding group antigen
WO1998043479A1 (en) * 1997-04-01 1998-10-08 Merieux Oravax 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012908A1 (en) * 1995-10-04 1997-04-10 Pasteur Merieux Serums & Vaccins NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI
WO1997037044A1 (en) * 1996-03-29 1997-10-09 Astra Aktiebolag Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
WO1997047646A1 (en) * 1996-06-10 1997-12-18 Boren Thomas Helicobacter pylori adhesin binding group antigen
WO1998043479A1 (en) * 1997-04-01 1998-10-08 Merieux Oravax 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE PIR 9 August 1997 (1997-08-09), TOMB J.F. ET AL.: "The complete genome sequence of the gastric pathogen Helicobacter pylori", XP002123530 *
ILVER ET AL: "HELICOBACTER PYLORI ADHESIN BINDING FUCOSYLATED HISTO-BLOOD GROUP ANTIGENS REVEALED BY RETAGGING", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 279, no. 279, pages 373-377-377, XP002102908, ISSN: 0036-8075 *
TOMB J -F ET AL: "THE COMPLETE GENOME SEQUENCE OF THE GASTRIC PATHOGEN HELICOBACTER PYLORI", NATURE,GB,MACMILLAN JOURNALS LTD. LONDON, vol. 388, no. 6642, pages 539-547,TABEL, XP002062106, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
AU4718999A (en) 2000-01-17
WO2000000614A2 (en) 2000-01-06
CA2329264A1 (en) 2000-01-06
WO2000000614A9 (en) 2000-03-30

Similar Documents

Publication Publication Date Title
WO1998004702A3 (en) Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use
MY119003A (en) Bacterial antigens and vaccine compositions
CA2294516A1 (en) Ikk-.beta. proteins, nucleic acids and methods
WO2000040614A3 (en) Characterization of the soc/crac calcium channel protein family
EP2261348A3 (en) Neisseria meningitidis antigens and compositions
FR2637612B1 (en) NUCLEOTIDE SEQUENCES ENCODING A PROTEIN WITH UREASIC ACTIVITY
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
CA2170515A1 (en) Nucleotide sequences for novel protein tyrosine phosphatases
CA2294566A1 (en) Ikk-.alpha. proteins, nucleic acids and methods
WO2004087062A3 (en) Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
WO2000012535A3 (en) Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
CA2273823A1 (en) Polypeptides encoded by a human lipase-like gene, compositions and methods
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
AU5776799A (en) Modified hcv peptide vaccines
EP1443055A3 (en) Interleukins-21 and 22
AU3711597A (en) A novel galanin receptor
WO2000000614A3 (en) NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI)
WO2001098355A3 (en) Cgi-69 compositions and methods of use
ATE375390T1 (en) G-PROTEIN-COUPLED RECEPTOR-LIKE PROTEINS
CA2323506A1 (en) Mammalian blood loss-induced gene, kd312
WO1998044094A3 (en) Helicobacter aliphatic amidase polypeptides, dna sequences encoding those polypeptides and uses thereof
NZ512308A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000046242A3 (en) 19 KILODALTON PROTEIN OF $i(HELICOBACTER PYLORI)
WO2002097036A3 (en) Compositions and methods for adipose abundant protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/14-14/14, DRAWINGS, REPLACED BY NEW PAGES 1/13-13/13; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2329264

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 09720560

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase